April 3, 2017
RegMed Investors’ (RMi) closing bell analysis: hitting the skids again
March 31, 2017
RegMed Investors’ (RMi) closing bell analysis: rock-paper-scissors
March 30, 2017
RegMed Investors’ (RMi) closing bell analysis: the sector’s Icarus effect
March 29, 2017
RegMed Investors’ (RMi) closing bell analysis: is the sector blowing name bubbles?
March 28, 2017
RegMed Investors’ (RMi) closing bell analysis: bottom fishing, playing the sector for tomorrow’s trade or both…
March 27, 2017
RegMed Investors’ (RMi) closing bell analysis, a wild ride as the sector jumps after an ignominious open
March 23, 2017
RegMed Investors’ (RMi) closing bell analysis: talk about resistance and support in this sector and that market
March 22, 2017
RegMed Investors’ (RMi) closing bell analysis: the drumbeat of altering perspective
March 21, 2017
RegMed Investors’ (RMi) closing bell analysis: the sector sheds its upside
March 20, 2017
RegMed Investors’ (RMi) closing bell analysis: mid-day the NASDAQ hit an all-time high before closing just about flat
March 17, 2017
RegMed Investors’ (RMi) closing bell analysis: the quadruple witch was on its broom
March 16, 2017
RegMed Investors’ (RMi) closing bell analysis: momentum prods the sector
March 15, 2017
RegMed Investors’ (RMi) closing bell analysis: a goldilocks week, so far …
March 14, 2017
RegMed Investors’ (RMi) closing bell analysis: snowshoes were needed
March 13, 2017
RegMed Investors’ (RMi) closing bell analysis: the pressing challenge to the sector, inevitability?
March 10, 2017
RegMed Investors’ (RMi) closing bell analysis: a week packed with FY16’s financial results
March 9, 2017
RegMed Investors’ (RMi) closing bell analysis: financial results cloud the present
March 8, 2017
RegMed Investors’ (RMi) closing bell analysis: the trend is up
March 7, 2017
RegMed Investors’ (RMi) closing bell analysis: where is the bong - no one is feelin’ the high
March 6, 2017
RegMed Investors’ (RMi) closing bell analyses, sector challenge - fear of failure as they …
March 3, 2017
RegMed Investors’ (RMi) closing bell analysis, following the sector day by day
March 2, 2017
RegMed Investors’ (RMi) closing bell analysis, biotech is breaking out and cell therapy is breaking down
March 1, 2017
RegMed Investors’ (RMi) closing bell analysis, the sector that wished it could
February 28, 2017
RegMed Investors’ (RMi) closing bell analysis, CEO compensation remains strong
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2026 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.